Treating patients presenting with advanced glaucoma--should we reconsider current practice?
- PMID: 21097788
- DOI: 10.1136/bjo.2010.188128
Treating patients presenting with advanced glaucoma--should we reconsider current practice?
Abstract
The management of patients presenting with advanced glaucoma presents a challenge to glaucoma clinicians. Presentation with advanced visual field loss is an important risk factor for progression to blindness in the affected eye(s) during the patients' lifetime. Maximising intraocular pressure (IOP) control in such situations is likely to minimise the risk of further visual field deterioration thus either preventing or slowing progression to blindness. Currently most patients presenting with advanced disease in the UK are managed on an escalating regime of medical treatment. Should this fail glaucoma surgery is usually employed to further lower IOP. Although glaucoma surgery is generally a safe and successful intervention it carries a small risk of severe visual loss and is considered by many clinicians as an intervention only to be used following failure of medical treatment. Recently however the National Institute for Clinical Excellence has suggested in its clinical guidelines for management of ocular hypertension and glaucoma that primary surgery should be offered to patients presenting with advanced glaucomatous visual field loss. This is contrary to the practice of most UK ophthalmologists. In this review the current available evidence underlying the management of presentation with advanced disease is examined.
Similar articles
-
Advanced glaucoma at diagnosis: current perspectives.Eye (Lond). 2020 Jan;34(1):116-128. doi: 10.1038/s41433-019-0637-2. Epub 2019 Nov 18. Eye (Lond). 2020. PMID: 31740802 Free PMC article. Review.
-
Risk factors for late presentation in chronic glaucoma.Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2251-7. Invest Ophthalmol Vis Sci. 1999. PMID: 10476790 Clinical Trial.
-
[Aiming for zero blindness].Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Nippon Ganka Gakkai Zasshi. 2015. PMID: 25854109 Review. Japanese.
-
Profile of the glaucomas and intervention in a large eye care centre in south-east Nepal.Nepal J Ophthalmol. 2010 Jan-Jun;2(1):3-9. doi: 10.3126/nepjoph.v2i1.3697. Nepal J Ophthalmol. 2010. PMID: 21141320
-
Attitudes of consultant ophthalmologists in the UK to initial management of glaucoma patients presenting with severe visual field loss: a national survey.Clin Exp Ophthalmol. 2011 Dec;39(9):858-64. doi: 10.1111/j.1442-9071.2011.02574.x. Epub 2011 Jun 14. Clin Exp Ophthalmol. 2011. PMID: 21631674
Cited by
-
Structural Change Can Be Detected in Advanced-Glaucoma Eyes.Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT511-8. doi: 10.1167/iovs.15-18929. Invest Ophthalmol Vis Sci. 2016. PMID: 27454660 Free PMC article.
-
Advanced glaucoma at diagnosis: current perspectives.Eye (Lond). 2020 Jan;34(1):116-128. doi: 10.1038/s41433-019-0637-2. Epub 2019 Nov 18. Eye (Lond). 2020. PMID: 31740802 Free PMC article. Review.
-
Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.Clin Ophthalmol. 2021 Jun 24;15:2683-2692. doi: 10.2147/OPTH.S318897. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34194222 Free PMC article.
-
Global rates of glaucoma surgery.Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2609-15. doi: 10.1007/s00417-013-2464-7. Epub 2013 Sep 26. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 24068439
-
Gradually Then Suddenly? Decline in Vision-Related Quality of Life as Glaucoma Worsens.J Ophthalmol. 2017;2017:1621640. doi: 10.1155/2017/1621640. Epub 2017 Apr 2. J Ophthalmol. 2017. PMID: 28469940 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical